康格罗尔 - - 扩大急性冠状动脉综合征患者的治疗选择
Jacek Kubica1, Piotr Adamski2, Sławomir Dobrzycki3
1Department of Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland.
Cardiology journal
|November 15, 2023
概括
康格洛尔是一种静脉注射的P2Y12抗剂,在穿皮冠状动脉干预中提供快速和强大的血小板抑制作用. 它有效地减少了血栓并发症与可管理的出血风险,特别是在高风险患者群体.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 干预心脏病学 干预心脏病学
背景情况:
- 康格洛尔是唯一的静脉注射P2Y12受体对抗剂,作为一种腺三酸盐模拟剂.
- 它通过直接与P2Y12受体结合,提供快速,强效和可逆的血小板抑制.
研究的目的:
- 评估康格罗尔在减少皮肤穿冠状动脉干预 (PCI) 期间周围手术血栓并发症方面的疗效和安全性.
- 在特定患者群体中突出显示格罗罗比口服P2Y12抑制剂的优势.
主要方法:
- 分析了来自三个关键试验的数据:冠军平台,冠军PCI和冠军PHOENIX.
- 评估坎格雷勒的药理动力学和药理动力学特性,包括迅速发病和短半衰期.
主要成果:
- 康格洛尔显著降低了PCI中围手术性血栓事件的风险.
- 这种药物与出血事件的轻微增加有关.
- 药物动力学特性克服了口服药物的局限性,特别是在急性冠状动脉综合征中.
结论:
- 康格洛尔是接受PCI的P2Y12受体抑制剂原始患者的有价值的选择,提供卓越的周围手术保护.
- 在患有口服P2Y12抑制剂药理动力学/药理动力学障碍的患者中,它特别有益.
- 指导方针建议在特定的急性和稳定的PCI环境中考虑使用.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Angina IV: Management
9
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
9
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
539
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
539
Angina V: Nursing Management
18
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
18
Acute Coronary Syndrome V: Nursing Management
15
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
15


